Deals



Phillips Plastics Corporation to acquire 100% of the shares of Medisize Corporation


Posted: 20th July 2011 10:19

Medisize Corporation has announced the decision of Phillips Plastics Corporation to acquire Medisize Corporation.  Phillips Plastics Corporation is a global leader in design, engineering and manufacturing for the medical, consumer, defence and automotive industries. The acquisition will create a global, vertically integrated healthcare company with greater ability to meet customers’ demands.

Ratos, the owner of Medisize has entered into a Share Sale and Purchase Agreement to sell the entire share capital of Medisize Corporation to Phillips Plastics Corporation (Phillips).

The acquisition will strengthen both companies´ positions in the healthcare market since the two companies with complementary strategic visions and product technologies will bring great benefits to their customers.

Coming Together to Serve Customers Even Better

“We are bringing together two long-standing leaders in OEM manufacturing for the healthcare market with more than 30 years of experience in meeting customer needs," said Willem van den Bruinhorst, CEO of Medisize Corporation. "By combining our strengths, we are not only creating an industry leading portfolio of expertise and services, we are also enhancing to provide a wider range of technologies to serve our customerson a global level.

Phillips President and CEO Matt Jennings commented, “Medisize has a world-class management team and European footprint, with demonstrated capabilities in high-volume manufacturing and high-speed automation that will strengthen Phillips’ service offering and global reach. This is a very positive development for each company’s customers, suppliers, and employees.

Both companies have full regulatory compliance and operate within controlled manufacturing environments.

The acquisition is subject to approval from the relevant competition authorities and is expected to be completedby the end of August 2011.

After the transaction is complete, Medisize will continue to operate under its own name as the European division of Phillips and Willem van den Bruinhorst will continue as President of Medisize and report directly to Phillips President and CEO, Matt Jennings.

 

Lead Advisor to Recapital Investment Group
Thomas W.  Shreve, Chief Executive Officer of Recapital Group commented:
"The dedication of the [HFW] team was impressive, the expertise and experience made available to us were consistently excellent, and the use of lawyers in different time zones to keep the process moving forward 24 hours a day was nicely done."
James Lewis and Brian Gordon both advised on the deal. James can be contacted on +44 (0)20 7264 8322 or by email at james.lewis@hfw.com
 
Brian Can be contacted on +65 6305 9533 or by email at brian.gordon@hfw.com
Lead Advisor to Recapital Investment Group
Thomas W.  Shreve, Chief Executive Officer of Recapital Group commented:
"The dedication of the [HFW] team was impressive, the expertise and experience made available to us were consistently excellent, and the use of lawyers in different time zones to keep the process moving forward 24 hours a day was nicely done."
James Lewis and Brian Gordon both advised on the deal. James can be contacted on +44 (0)20 7264 8322 or by email at james.lewis@hfw.com
 
Brian Can be contacted on +65 6305 9533 or by email at brian.gordon@hfw.com

Related articles